Clinical Trial Update: ATL001 in Patients With Advanced Unresectable or Metastatic NSCLC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of ATL001 in advanced unresectable or metastatic non-small cell lung cancer has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ATL001

Snippet

Sponsor: Achilles Therapeutics UK Limited | Conditions: Advanced Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-03-10